• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Strain ratio adds objectivity, improves sensitivity in ultrasound elastography

Article

Adding strain ratio measurement to ultrasound elastography would provide a more objective way to differentiate benign from malignant breast lesions than a five-point scoring system now being used, according to a study presented at the European Congress of Radiology in March.

Adding strain ratio measurement to ultrasound elastography would provide a more objective way to differentiate benign from malignant breast lesions than a five-point scoring system now being used, according to a study presented at the European Congress of Radiology in March.

From January 2008 to April 2009, 559 lesions from 428 consecutive patients were diagnosed by ultrasound elastography. The strain ratio of the lesion was calculated. Final diagnosis was confirmed by histopathology. The receiver operating characteristic (ROC) area under the curve and cutoff point were used to assess diagnostic performance.

The benign lesions produced a mean strain ratio of 1.83. Malignant lesions produced a mean strain ratio of 8.38. When the researchers used a cutoff point of 3.05, ultrasound elastography had 92.4% sensitivity, 91.1% specificity, and 91.4% accuracy. The sensitivity was higher than the five-point scoring system, the study authors said.

Recent Videos
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Nina Kottler, MD, MS
Radiology Challenges with Breast Cancer Screening in Women with Breast Implants
Related Content
© 2024 MJH Life Sciences

All rights reserved.